Cancer Research Audrey Hepburn  Telomeres
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 50, 669-676, February 1, 1990]
© 1990 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bartles, J. R.
Right arrow Articles by Fayos, B. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bartles, J. R.
Right arrow Articles by Fayos, B. E.

Peroxisome Proliferator-induced Alterations in the Expression and Modification of Rat Hepatocyte Plasma Membrane Proteins1

James R. Bartles2, Satya Khuon, Xuanhui Lin, Liqin Zhang, Janardan K. Reddy, M. Sambasiva Rao, Steven T. Isoye, Cheryl L. Nehme and Barbara E. Fayos

Departments of Cell Molecular and Structural Biology [J. R. B., S. K., X. L., L. Z., S. T. I., C. L. N., B. E. F.] and Pathology [J. K. R., M. S. R.], Northwestern University Medical School, Chicago, Illinois 60611

Rats were fed the peroxisome proliferator ciprofibrate (0.025%), and the effects on the expression, modification, and localization of seven domain-specific integral proteins of the rat hepatocyte plasma membrane were assessed using a combination of immunoblotting, -precipitation, and -fluorescence. Ciprofibrate caused the down-regulation of five of the plasma membrane proteins (the epidermal growth factor receptor, the asialoglycoprotein receptor, HA 321, HA 4, and dipeptidylpeptidase IV) and induced the expression of a more basic, lower-Mr isoform of the basolateral plasma membrane protein CE 9. Pulse labeling, chemical deglycosylation, and 125I-wheat germ lectin blotting suggested that the ciprofibrate-induced isoform of CE 9 differed in the posttranslational modification of its oligosaccharides and contained more sialic acid. These changes in hepatocyte surface differentiation were first observed between Days 1 and 5 on the ciprofibrate-containing diet, coincident with other aspects of the pleiotropic response of the hepatocyte to peroxisome proliferators, e.g., the induction of the Mr 78,000 peroxisome proliferation-associated protein. The effects were reversed within 2–3 weeks upon removal of ciprofibrate. The three other peroxisome proliferators tested, di(2-ethylhexyl)phthalate, clofibrate, and Wy-14,643, were found to exert most of these same effects on the expression and modification of the hepatocyte plasma membrane proteins, but the compounds differed in relative potency. The ciprofibrate-induced decreases in the concentrations of the epidermal growth factor receptor, the asialoglycoprotein receptor, HA 321, and HA 4 were similar to the selective down-regulation of these proteins observed transiently during the period of hepatocyte proliferation following two-thirds hepatectomy. Other compounds frequently used in studies of liver enzyme induction and carcinogenesis, the antioxidants ethoxyquin and butylated hydroxyanisole and the liver tumor promoter phenobarbital, were not as effective as ciprofibrate or two-thirds hepatectomy at causing the down-regulation of these proteins. The induction of the lower-Mr isoform of the basolateral plasma membrane protein CE 9 was not observed following two-thirds hepatectomy or upon the feeding of the antioxidants or phenobarbital but was specific to the feeding of the peroxisome proliferators.

1 Supported by Grant BC-676 from the American Cancer Society (to J. R. B.); Grants RR05370 (to J. R. B.), R37 GM23750 (to J. K. R.), and CA36130 (to M. S. R.) from the National Institutes of Health; and a grant from the Northwestern University Research Grants Committee (to J. R. B.).

2 To whom correspondence should be addressed, at the Department of Cell Molecular and Structural Biology, Northwestern University Medical School, 303 East Chicago Avenue, Chicago, IL 60611.

Received 5/22/89. Revised 9/29/89. Accepted 10/31/89.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
J. C. Corton, U. Apte, S. P. Anderson, P. Limaye, L. Yoon, J. Latendresse, C. Dunn, J. I. Everitt, K. A. Voss, C. Swanson, et al.
Mimetics of Caloric Restriction Include Agonists of Lipid-activated Nuclear Receptors
J. Biol. Chem., October 29, 2004; 279(44): 46204 - 46212.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
S Chevalier, N Macdonald, and R. Roberts
Induction of DNA replication by peroxisome proliferators is independent of both tumour necrosis factor (alpha) priming and EGF-receptor tyrosine kinase activity
J. Cell Sci., January 12, 1999; 112(24): 4785 - 4791.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1990 by the American Association for Cancer Research.